lobbying_activities: 1582963

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1582963	92cb16db-95d1-4c30-97dd-ec3421af58b2	Q3	CHAMBER HILL STRATEGIES	400645947	GLAXOSMITHKLINE, INC.	2014	third_quarter	MMM	Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform issues included within P.L. 113-93, Protecting Access to Medicare Act of 2014; and S.1932, Better Care, Lower Cost Act.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2014-10-08T16:14:00.867000-04:00